Skip to main contentAI and Advanced
/
HSIL · BSEBSE SENSEX77,656.09+0.37%BSE |
NIFTY 5024,334.55+0.48%NSE |
NIFTY BANK57,514.2-0.02%NSE |
NIFTY IT30,771.8+0.57%NSE |
NIFTY AUTO29,216.9+0.40%NSE |
NIFTY FMCG47,706.95+0.38%NSE |
NIFTY PHARMA26,564+0.85%NSE |
NIFTY 50023,611.6+0.42%NSE |
HS
BSE · Equity shares · Medical Equipment & Supplies-8.35 · -2.21%
Hemant Surgical Industries Ltd HSIL
NSE:Not available
BSE:INR 370
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for HSIL
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 378.35
Day rangeINR 363 — INR 380
52-week rangeINR 328.35 — INR 400
Volume57,600
Market cap539.49
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)166.73
Net Income (INR Cr)12.83
EPS10.85
Research path: Interpret Hemant Surgical Industries Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
HSILHemant Surgical Industries Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Mar-26 | Sep-25 | FY25-26 |
|---|---|---|---|
| Revenue | 166.73 | 64.26 | 230.99 |
| Net Profit | 12.83 | 5.41 | 18.23 |
| EPS | 10.85 | 5.09 | 15.42 |
| Cash EPS | 10.44 | 4.71 | 15.15 |
| OPM % | 11.52 | 15.42 | 12.61 |
| NPM % | 7.69 | 8.41 | 7.89 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m11.52
Net Profit Margin 12m7.69
Valuation
Price to Sale Ratio3.24
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 52.83%
- Public shareholders
- 47.17%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE corporate filing · 10 Jul 2026, 5:30 am
Revised Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon, USABSE corporate filing · 9 Jun 2026, 5:30 am
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE corporate filing · 9 Jun 2026, 5:30 am
Announcement under Regulation 30 (LODR)-Updates on AcquisitionBSE corporate filing · 1 Jun 2026, 5:30 am
Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE corporate filing · 30 May 2026, 5:30 am
Announcement under Regulation 30 (LODR)-AcquisitionBSE corporate filing · 27 May 2026, 5:30 am
Corporate actions
Events
- board MeetingsResults
- board MeetingsResults
- board MeetingsResults
- board MeetingsResults
- board MeetingsResults
- board MeetingsResults
- board MeetingsIssue Of Warrants
- board MeetingsPreferential Issue of shares
ShareKeyX Community
Discussion and sentiment for Hemant Surgical Industries Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Medical Equipment & Supplies
- Sector
- Healthcare
- Website
- www.hemantsurgical.com
- Address
- 502, Ecstacy Business Park, CoOp Society Limited,, 5th Floor, J.S.D. Road, Mulund (West), Mumbai, Maharashtra, 400080
- NSE Code
- HSIL
- BSE Code
- 543916
- Listing date
- 5 Jun 2023
- Face value
- 10
- Market lot
- 400
- CIN
- L33110MH1989PLC051133
- Company email
- cs@hemantsurgical.com
- Company phone
- 022-25915289
Leadership and officers
- Chairman & Managing Director
- Hanskumar Shamji Shah
- Whole-time Director & CFO
- Kaushik Hanskumar Shah
- Whole-Time Director
- Hemant Praful Shah
- Non- Executive Director
- Nehal Babu Karelia
- Non - Executive Independent Director
- Mr. Manish Kankani
- Non - Executive Independent Director
- Mrs. Kshama Dharnidharka
- Company Secretary & Compliance Officer
- Mrs. Meenal Ajmera
Questions
Stock FAQ
What is the symbol and ISIN of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has the symbol HSIL and ISIN - INE0GYI01028.
What is the current price of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd is currently trading at INR 370.00.
What are the year high and year low of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a year high of INR 400.00 and a year low of INR 328.35.
What is the market capitalization of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a market capitalization of INR 539.49 crore.
What is the P/E ratio of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a P/E ratio of NA.
What is the dividend yield of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a dividend yield of NA.
How is the financial performance of Hemant Surgical Industries Ltd based on revenue, net income, and EPS?
Hemant Surgical Industries Ltd has revenue of INR 166.73 crore, net income of INR 12.83 crore, and EPS of NA.
What is the book value of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a book value of NA.
What is the debt-to-equity ratio of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Hemant Surgical Industries Ltd?
Hemant Surgical Industries Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 3.24.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.